Explore JAMA Network Open’s collection on clinical pharmacy and pharmacology, including topics in drug safety and development, pharmacogenetics, and more.
This cohort study investigates whether positive and negative expectations are associated with systemic adverse effects among adults receiving their second dose of COVID-19 vaccines.
This cluster randomized trial evaluates the effects of general practitioner–led family conferences on deprescribing and hospitalizations in community-dwelling older adults with frailty.
This cohort study examines survival among patients receiving antibiotic therapy concurrent with chemotherapy with gemcitabine or fluorouracil for metastatic pancreatic ductal adenocarcinoma.
This cross-sectional study examines how key demographic and predisposing factors are associated with consumer trust in pharmaceutical manufacturers.
This cross-sectional study explores the health-related values and preferences of adults who had been preterm infants and parents of preterm infants concerning the use of cyclo-oxygenase inhibitors in preterm infants to prevent patent ductus arteriosus–related morbidity and mortality.
This cohort study examines the association of the use of leukotriene-receptor antagonists during pregnancy with the risk of neuropsychiatric events in offspring.
This cohort study assesses sex disparities in nonacceptance of statin therapy and assess their association with low-density lipoprotein (LDL) cholesterol control.
This systematic review evaluates risk prediction models of cardiotoxicity for patients with breast cancer.
This cohort study investigates the association of sodium-glucose transport protein 2 inhibitor (SGLT2i) use and the incidence of acute kidney injury (AKI) in patients with type 2 diabetes in Taiwan.
This randomized clinical trial of adults with treatment-resistant depression assesses whether adjunctive simvastatin therapy improves depressive symptoms compared with placebo.
This cohort study assesses antipsychotic medication use among older US adults, including rates of and patient characteristics associated with discontinuation, following infection-related hospitalization.
This cross-sectional study examines the benzodiazepine receptor agonists (BZRA) prescribing rate for insomnia among adult patients in primary health care facilities (PHFs) in China.
This cohort study examines the postapproval processes and timing for making palbociclib, ribociclib, and abemaciclib available to patients with metastatic breast cancer in a high-income country.
This cohort study examines the incidence of bradycardia occurring during or after administration of remdesivir in patients with COVID-19 through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic (FACT) Pharmacovigilance Project.
This randomized equivalence and noninferiority trial compares safety and efficacy of enoxaparin vs rivaroxaban 2.5 or 5 mg for patients with acute coronary syndrome (ACS) in the acute phase.
This cross-sectional study evaluates trends in out-of-pocket costs for and characteristics of pharmacy-dispensed buprenorphine medications for opioid use disorder treatment by type of payer from 2015 to 2020.
This cohort study examines outcomes associated with tapering of opioid therapy in patients who have received stable doses for 1 year, including subcohorts of those with hypertension or diabetes.
This cross-sectional study evaluates the association between the 2021 varenicline tartrate recall and prescribing of varenicline and other medications for nicotine dependence in a large US national patient cohort.
This case-control study compares the long-term incidence of congestive heart failure in patients treated for breast cancer or lymphoma with anthracycline therapy compared with healthy controls from the same community.
Customize your JAMA Network experience by selecting one or more topics from the list below.